Skip to main content

Lenire Tinnitus Treatment Device

Lenire is a tinnitus treatment device proven in a large-scale clinical trial to reduce the severity of tinnitus. Use it from the comfort of home to manage your tinnitus with the help of a qualified audiologist. Soothing sounds and gentle pulses on your tongue help you pay less attention to your tinnitus.

Learn More About Tinnitus

How Lenire Works

Lenire plays sounds from headphones and provides gentle pulses to the tongue via a Tonguetip. The sounds and pulses work together to retrain your brain. As a result, you pay less attention to your tinnitus reducing its impact on your day-to-day life.

Lenire is the first device of its kind to receive a grant of approval from the FDA to treat tinnitus. This follows a large-scale clinical trial designed to meet the FDA’s requirements during which 83% of patients recommended Lenire for the treatment of tinnitus. The largescale trial’s results were consistent with real-world evidence from 204 patients*.

Find out if you are a candidate for Lenire. Call us at 415-346-6886 to schedule a Tinnitus Assessment with our audiologist who specializes in tinnitus management.

During this appointment the audiologist will do a thorough tinnitus inventory and assessment, an audiologic assessment, determine if you are a candidate for Lenire and develop a tinnitus treatment plan for you.

Or Book Online Here

Scientifically Proven Tinnitus Relief

  • Lenire tinnitus treatment device is proven to be safe and effective in a landmark clinical trial and has received a De Novo FDA grant approval following the success of its most recent clinical trial.
  • Lenire is the only FDA approved bimodal neuromodulation tinnitus-specific treatment device.
  • TENT-A3 was a controlled trial, designed in collaboration with the United States of America’s FDA.
  • TENT-A3 High Level Results: 88.6% of clinical trial participants would recommend treating tinnitus with Lenire. Lenire offered significant relief for 70.5% of those with moderate or worse tinnitus where sound-only therapy had no clinical impact.
  • No device or treatment related serious adverse events were reported by trial participants.
Schedule a Tinnitus Evaluation

Washington Post Publishes In-Depth Lenire Feature

Pulitzer Prize winning newspaper, The Washington Post, published a feature on bimodal neuromodulation and Lenire, the first and only tinnitus treatment to be granted FDA Approval.

Read this in-depth piece to learn about Susan Rivas’ “life-changing” Lenire experience, and how treatment with Lenire turned Bojan Radojevic’s tinnitus from “loud screaming” to “virtually non-existent”.

The Washington Post’s ‘most-read’ article also features insights from leading audiologists, and interactive content where you can hear samples from Lenire’s patented soundscapes.

Close Menu